Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1984 Jul;26(1):31-4.
doi: 10.1128/aac.26.1.31.

Intranasal Interferon-Alpha 2 for Prevention of Natural Rhinovirus Colds

Free PMC article
Clinical Trial

Intranasal Interferon-Alpha 2 for Prevention of Natural Rhinovirus Colds

B M Farr et al. Antimicrob Agents Chemother. .
Free PMC article

Abstract

The prophylactic activity of intranasal human interferon-alpha 2 (HuIFN-alpha 2) against natural rhinovirus colds was determined in a randomized, double-blind, placebo-controlled trial. A total of 304 working adults self-administered sprays of HuIFN-alpha 2 (10(7) IU/day) or a placebo once daily. During 22 days of treatment, 13 (8.5%) placebo recipients but no HuIFN-alpha 2 recipients had respiratory illnesses documented secondary to rhinovirus infection (P = 0.0002). The occurrence of illness with symptoms of tracheobronchitis was lower in HuIFN-alpha 2 recipients (one eposide) than in placebo recipients (eight episodes, P = 0.04). In contrast, the frequency of nasal symptoms and the overall rate of respiratory illness were significantly higher in HuIFN-alpha 2 recipients during weeks 2 and 3 of treatment. Symptoms (obstruction, discomfort, blood-tinged nasal mucus) or signs (punctate bleeding sites, erosions, superficial ulcerations) of nasal irritation occurred in 40 HuIFN-alpha 2 recipients during week 3 (P less than 0.0001 versus placebo recipients). Although the results of the current study were partially confounded by the nasal side effects of prolonged administration, they showed that intranasal HuIFN-alpha 2 was efficacious in preventing rhinovirus colds under natural conditions.

Similar articles

See all similar articles

Cited by 25 articles

See all "Cited by" articles

References

    1. N Engl J Med. 1966 Dec 8;275(23):1261-8 - PubMed
    1. J Infect Dis. 1983 Nov;148(5):914-21 - PubMed
    1. Nature. 1975 Oct 23;257(5528):682-4 - PubMed
    1. Antimicrob Agents Chemother. 1978 Oct;14(4):596-600 - PubMed
    1. Proc Soc Exp Biol Med. 1980 Jun;164(2):146-52 - PubMed

Publication types

Substances

LinkOut - more resources

Feedback